143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
GlyNAC supplementation found to improve cognitive decline and brain health in aging

GlyNAC supplementation found to improve cognitive decline and brain health in aging

by Homa Shalchi,Baylor College of MedicineStudy experimental details. GCLC and GCLM = catalytic and modifier subunits of glutamate cysteine ligase enzyme; GSS = glutathione synthetase enzyme; GL

GlyNAC supplementation found to improve cognitive decline and brain health in aging

by Homa Shalchi,Baylor College of MedicineStudy experimental details. GCLC and GCLM = catalytic and modifier subunits of glutamate cysteine ligase enzyme; GSS = glutathione synthetase enzyme; GL
Study reveals broader impact of Alzheimer's on brain function

Study reveals broader impact of Alzheimer's on brain function

by Stephen Fontenot,University of Texas at DallasAlzheimer's disease and aging are associated with distinct patterns of brain network disruption. Alzheimer's (left) exerts widespread imp

Study reveals broader impact of Alzheimer's on brain function

by Stephen Fontenot,University of Texas at DallasAlzheimer's disease and aging are associated with distinct patterns of brain network disruption. Alzheimer's (left) exerts widespread imp
Study models how ketamine's molecular action leads to its effects on the brain

Study models how ketamine's molecular action leads to its effects on the brain

by Massachusetts Institute of TechnologyA spectrogram of brain rhythm frequencies over time predicted by the team's model. After a first, moderate dose of ketamine gamma brain rhythm power (w

Study models how ketamine's molecular action leads to its effects on the brain

by Massachusetts Institute of TechnologyA spectrogram of brain rhythm frequencies over time predicted by the team's model. After a first, moderate dose of ketamine gamma brain rhythm power (w
Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41
First study of the microvessels connecting the human cranium and brain

First study of the microvessels connecting the human cranium and brain

by CENIEHMicrophoramine distribution in adult human skulls. Credit: Bruner and EisovaEmiliano Bruner, a paleoneurologist at the Centro Nacional de Investigación sobre la Evolución Humana (CENIEH), has

First study of the microvessels connecting the human cranium and brain

by CENIEHMicrophoramine distribution in adult human skulls. Credit: Bruner and EisovaEmiliano Bruner, a paleoneurologist at the Centro Nacional de Investigación sobre la Evolución Humana (CENIEH), has
CKD linked to greater neuromuscular fatigability

CKD linked to greater neuromuscular fatigability

by Elana Gotkine HealthDay ReporterChronic kidney disease (CKD) is associated with greater neuromuscular fatigability, which increases with fatigue severity, according to a study published online Dec.

CKD linked to greater neuromuscular fatigability

by Elana Gotkine HealthDay ReporterChronic kidney disease (CKD) is associated with greater neuromuscular fatigability, which increases with fatigue severity, according to a study published online Dec.
Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q
Counting from left to right feels 'natural,' but new research shows our brains count faster from bottom to top

Counting from left to right feels 'natural,' but new research shows our brains count faster from bottom to top

by Luke Greenacre, Adrian Dyer, Jair Garcia and Scarlett Howard,The ConversationTesting how participants show preferences for either horizontal or vertical mental number lines by indicating the

Counting from left to right feels 'natural,' but new research shows our brains count faster from bottom to top

by Luke Greenacre, Adrian Dyer, Jair Garcia and Scarlett Howard,The ConversationTesting how participants show preferences for either horizontal or vertical mental number lines by indicating the
Global dementia cases set to triple by 2050 unless countries address risk factors

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m
New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules
Simple tool shows life expectancy after dementia diagnosis

Simple tool shows life expectancy after dementia diagnosis

by Karolinska InstitutetTables illustrate three-year survival probabilities for people with dementia diagnosed in primary care. Dark green indicates a low risk of death while dark purple indicate

Simple tool shows life expectancy after dementia diagnosis

by Karolinska InstitutetTables illustrate three-year survival probabilities for people with dementia diagnosed in primary care. Dark green indicates a low risk of death while dark purple indicate